• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC TORCON NB ADVANTAGE VAN SCHIE BEACON TIP SEEKING CATHETER; DQO CATHETER, INTRAVASCULAR, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC TORCON NB ADVANTAGE VAN SCHIE BEACON TIP SEEKING CATHETER; DQO CATHETER, INTRAVASCULAR, DIAGNOSTIC Back to Search Results
Model Number N/A
Device Problems Tip breakage (1638); Split (2537)
Patient Problem Aneurysm (1708)
Event Date 12/04/2014
Event Type  Injury  
Event Description
As per problem statement."in the catheter vanschie 3 the tip split into fragments." during an aortic stent graft implantation procedure on a male patient with pre-existing condition of an abdominal aortic aneurysm, the tip of the vanshie 3 catheter split into fragments.The fragments were retrieved with an endovascular snare.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
 
Manufacturer Narrative
(b)(4).The event is currently under investigation.
 
Manufacturer Narrative
(b)(4).Event evaluation: a review of complaint history, instructions for use (ifu), quality control and a visual examination was conducted during the investigation.One device was returned in an opened and used condition and one device in an unused condition.The visual examination of the one returned, opened and used device noted that the distal tip of the catheter had split.There is no evidence to suggest that the product was not manufactured to specifications.The product is shipped with an ifu which states under precautions: "due to thinwall construction, extreme care must be exercised during manipulation and withdrawal.Catheter insertion through a synthetic vascular graft should be avoided whenever possible." / "the possible whiplash effect of the long, soft catheter tip must be considered during selective angiography." we are unable to determine with certainty the root cause for the reported difficulty.The appropriate internal personnel have been notified and we will continue to monitor for similar complaints.Quality engineering risk assessment was used to assess the risk of this complaint.The addition of this complaint does not change the conclusion that no further risk reduction is required.
 
Event Description
During an aortic stent graft implantation procedure on a male patient with pre-existing condition of an abdominal aortic aneurysm, the tip of the vanshie 3 catheter split into fragments.The fragments were retrieved with an endovascular snare.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
 
Manufacturer Narrative
A recall expansion was initiated on (b)(6) 2015.Another recall expansion was initiated on (b)(6) 2016 for any product manufactured with the beacon tip technology.This product is in scope of the recall.(b)(4).Event evaluation: a review of complaint history, instructions for use (ifu), quality control and a visual examination was conducted during the investigation.One device was returned in an opened and used condition and one device in an unused condition.The visual examination of the one returned, opened and used device noted that the distal tip of the catheter had split.There is no evidence to suggest that the product was not manufactured to specifications.The product is shipped with an ifu which states under precautions: "due to thin wall construction, extreme care must be exercised during manipulation and withdrawal.Catheter insertion through a synthetic vascular graft should be avoided whenever possible." / "the possible whiplash effect of the long, soft catheter tip must be considered during selective angiography." we are unable to determine with certainty the root cause for the reported difficulty.The appropriate internal personnel have been notified and we will continue to monitor for similar complaints.Quality engineering risk assessment was used to assess the risk of this complaint.The addition of this complaint does not change the conclusion that no further risk reduction is required.
 
Event Description
During an aortic stent graft implantation procedure on a male patient with pre-existing condition of an abdominal aortic aneurysm, the tip of the van schie 3 catheter split into fragments.The fragments were retrieved with an endovascular snare.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TORCON NB ADVANTAGE VAN SCHIE BEACON TIP SEEKING CATHETER
Type of Device
DQO CATHETER, INTRAVASCULAR, DIAGNOSTIC
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
rita harden
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key4434208
MDR Text Key5417913
Report Number1820334-2015-00040
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
Reporter Country CodePL
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,foreign,health profe
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 12/19/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/01/2017
Device Model NumberN/A
Device Catalogue NumberHNBR5.0-35-65-P-NS-VANSCHIE3
Device Lot Number4716078
Other Device ID NumberN/A
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer01/08/2015
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date12/04/2014
Device Age11 MO
Event Location Hospital
Initial Date Manufacturer Received 12/22/2014
Initial Date FDA Received01/15/2015
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received10/23/2015
08/30/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/01/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-